52
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial

, , , , , & show all
Pages 499-508 | Published online: 05 Feb 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Bartolome R Celli, Maryam Navaie, Zhun Xu, Soojin Cho-Reyes, Carole Dembek & Todd P Gilmer. (2019) Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1019-1031.
Read now

Articles from other publishers (2)

I Re Heo, Tae Hoon Kim, Jong Hwan Jeong, Manbong Heo, Sun Mi Ju, Jung-Wan Yoo, Seung Jun Lee, Yu Ji Cho, Yi Yeong Jeong, Jong Deog Lee & Ho Cheol Kim. (2023) Impact of Alcohol Consumption on Quality of Life, Depressive Mood and Metabolic Syndrome in Obstructive Lung Disease Patients: Analysis of Data from Korean National Health and Nutrition Examination Survey from 2014 and 2016. Tuberculosis and Respiratory Diseases 86:2, pages 111-119.
Crossref
Joseph F. Levy & Marjorie A. Rosenberg. (2019) A Latent Class Approach to Modeling Trajectories of Health Care Cost in Pediatric Cystic Fibrosis. Medical Decision Making 39:5, pages 593-604.
Crossref